Skip to main content
NCBI home page
Gut logoLink to Gut
. 1984 Apr;25(4):417–423. doi: 10.1136/gut.25.4.417

Clinical, biochemical, serological, histological and ultrastructural features of liver disease in drug abusers.

I V Weller, D Cohn, A Sierralta, M Mitcheson, M G Ross, L Montano, P Scheuer, H C Thomas
PMCID: PMC1432359  PMID: 6423458

Abstract

Heroin abusers are frequently found to have abnormal liver function tests and hepatic histology. Hepatitis viruses A, B, and NANB, other drugs or drug contaminants and excessive alcohol consumption are factors thought to contribute. One hundred and sixteen heroin abusers attending a London treatment centre were studied. Sixty two (53%) had a raised aspartate transaminase. This was not explained by current infection with hepatitis A and B, cytomegalo or Epstein-Barr viruses, excessive alcohol consumption (greater than 80 g/day) or concomitant drug taking. Abnormal liver function tests were as frequent in those with markers of current or past HBV infection as those without and there was evidence that both HBV infection and the cause of the abnormal liver function tests were acquired in the first few years of intravenous drug abuse. Liver biopsies from eight patients showed chronic hepatitis with a mild lobular and portal inflammatory infiltrate, fatty change and prominent sinusoidal cells. Electron microscopy showed cytoplasmic trilaminar tubular structures and dense fused membranes in dilated endoplasmic reticulum. These clinical, biochemical, serological, and histological features would suggest a major role for NANB virus infection in the aetiology of hepatitis in heroin abusers.

Full text

PDF
417

Images in this article

420Fig. 2
on p.420
420Fig. 3
on p.420
421Fig. 4
on p.421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROOKS F. P., DENEAU G. A., POTTER P., Jr, REINHOLD J. G., NORRIS R. F. Liver function tests in morphine-addicted and in nonaddicted rhesus monkeys. Gastroenterology. 1963 Mar;44:287–290. [PubMed] [Google Scholar]
  2. Bamber M., Murray A. K., Weller I. V., Morelli A., Scheuer P. J., Thomas H. C., Sherlock S. Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol. 1981 Oct;34(10):1175–1180. doi: 10.1136/jcp.34.10.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bamber M., Murray A., Arborgh B. A., Scheuer P. J., Kernoff P. B., Thomas H. C., Sherlock S. Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut. 1981 Oct;22(10):854–859. doi: 10.1136/gut.22.10.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bamber M., Murray A., Lewin J., Thomas H. C., Sherlock S. Ultrastructural features in chronic non-A, non-B (NANB) hepatitis: A controlled blind study. J Med Virol. 1981;8(4):267–275. doi: 10.1002/jmv.1890080407. [DOI] [PubMed] [Google Scholar]
  5. Bamber M., Thomas H. C., Bannister B., Sherlock S. Acute type A, B, and non-A, non-B hepatitis in a hospital population in London: clinical and epidemiological features. Gut. 1983 Jun;24(6):561–564. doi: 10.1136/gut.24.6.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blanck R. R., Ream N., Conrad M. Hepatitis B antigen and antibody in heroin users. Am J Gastroenterol. 1979 Feb;71(2):164–167. [PubMed] [Google Scholar]
  7. Boughton C. R., Hawkes R. A. Viral hepatitis and the drug cult: a brief socio-epidemiological study in Sydney. Aust N Z J Med. 1980 Apr;10(2):157–161. doi: 10.1111/j.1445-5994.1980.tb03704.x. [DOI] [PubMed] [Google Scholar]
  8. Busachi C. A., Realdi G., Alberti A., Badiali-De Giorgi L., Tremolada F. Ultrastructural changes in the liver of patients with chronic non-A, non-B hepatitis. J Med Virol. 1981;7(3):205–212. doi: 10.1002/jmv.1890070304. [DOI] [PubMed] [Google Scholar]
  9. Cherubin C. E., Hargrove R. L., Prince A. M. The serum hepatitis related antigen (SH) in illicit drug users. Am J Epidemiol. 1970 May;91(5):510–517. doi: 10.1093/oxfordjournals.aje.a121161. [DOI] [PubMed] [Google Scholar]
  10. Damjanovic V., Ross M., Brumfitt W. Studies on antibody to hepatitis A virus in children and adults in London. Infection. 1979;7(6):267–272. doi: 10.1007/BF01642145. [DOI] [PubMed] [Google Scholar]
  11. De Wolf-Peeters C., De Vos R., Desmet V., Ray M. B., Desmyter J., De Groote G., Fevery J., Broeckaert L., De Groote J. Human non-A, non-B hepatitis: ultrastructural alterations in hepatocytes. Liver. 1981 Mar;1(1):50–55. doi: 10.1111/j.1600-0676.1981.tb00021.x. [DOI] [PubMed] [Google Scholar]
  12. Edwards J. M., McSwiggan D. A. Studies on the diagnostic value of an immunofluorescence test for EB virus-specific IgM. J Clin Pathol. 1974 Aug;27(8):647–651. doi: 10.1136/jcp.27.8.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gmelin K., Kommerell B., Waldherr R., von Ehrlich B. Intranuclear virus-like particles in a case of sporadic non-A, non-B hepatitis. J Med Virol. 1980;5(4):317–322. doi: 10.1002/1096-9071(1980)5:4<317::aid-jmv1890050408>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  14. Gorodetzky C. W., Sapira J. D., Jasinski D. R., Martin W. R. Liver disease in narcotic addicts. I. The role of the drug. Clin Pharmacol Ther. 1968 Nov-Dec;9(6):720–724. doi: 10.1002/cpt196896720. [DOI] [PubMed] [Google Scholar]
  15. Grimaud J. A., Peyrol S., Vitvitski L., Chevallier-Queyron P., Trepo C. Hepatic intranuclear particles in patients with non-A, non-B hepatitis. N Engl J Med. 1980 Oct 2;303(14):818–819. doi: 10.1056/NEJM198010023031416. [DOI] [PubMed] [Google Scholar]
  16. Hollinger F. B., Mosley J. W., Szmuness W., Aach R. D., Peters R. L., Stevens C. Transfusion-transmitted viruses study: experimental evidence for two non-A, non-B, hepatitis agents. J Infect Dis. 1980 Sep;142(3):400–407. doi: 10.1093/infdis/142.3.400. [DOI] [PubMed] [Google Scholar]
  17. Ireton H. J., Gust I. D., Moon W. J., Lehmann N., Stening G. F., Smallwood R. A. The covert liver disease of drug addicts. Aust N Z J Med. 1974 Oct;4(5):444–449. doi: 10.1111/j.1445-5994.1974.tb03215.x. [DOI] [PubMed] [Google Scholar]
  18. Iwarson S., Lundin P., Holmgren J., Hermodsson S. Multiple attacks of hepatitis in drug addicts: biochemical, immunochemical, and morphologic characteristics. J Infect Dis. 1973 May;127(5):544–550. doi: 10.1093/infdis/127.5.544. [DOI] [PubMed] [Google Scholar]
  19. Jackson D., Tabor E., Gerety R. J. Acute non-A, non-B hepatitis: specific ultrastructural alterations in endoplasmic reticulum of infected hepatocytes. Lancet. 1979 Jun 9;1(8128):1249–1250. doi: 10.1016/s0140-6736(79)91938-x. [DOI] [PubMed] [Google Scholar]
  20. Jersild T., Johansen C., Balslöv J. T., Höjgaard K., Johansen A., Ott C. Hepatitis in young drug users. Scand J Gastroenterol Suppl. 1970;7:79–83. [PubMed] [Google Scholar]
  21. Kangro H. O. Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus. Br J Exp Pathol. 1980 Oct;61(5):512–520. [PMC free article] [PubMed] [Google Scholar]
  22. Karayiannis P., Scheuer P. J., Bamber M., Cohn D., Hurn B. A., Thomas H. C. Experimental infection of Tamarins with human non-A, non-B hepatitis virus. J Med Virol. 1983;11(3):251–256. doi: 10.1002/jmv.1890110308. [DOI] [PubMed] [Google Scholar]
  23. Kreek M. J., Dodes L., Kane S., Knobler J., Martin R. Long-term methadone maintenance therapy: effects on liver function. Ann Intern Med. 1972 Oct;77(4):598–602. doi: 10.7326/0003-4819-77-4-598. [DOI] [PubMed] [Google Scholar]
  24. Marciano-Cabral F., Rublee K. L., Carithers R. L., Jr, Galen E. A., Sobieski T. J., Cabral G. A. Chronic non-A, non-B hepatitis: ultrastructural and serologic studies. Hepatology. 1981 Nov-Dec;1(6):575–582. doi: 10.1002/hep.1840010603. [DOI] [PubMed] [Google Scholar]
  25. Miller D. J., Kleber H., Bloomer J. R. Chronic hepatitis associated with drug abuse: significance of hepatitis B virus. Yale J Biol Med. 1979 Jan-Feb;52(1):135–140. [PMC free article] [PubMed] [Google Scholar]
  26. Min K. W., Gyorkey F., Cain G. D. Talc granulomata in liver disease in narcotic addicts. Arch Pathol. 1974 Nov;98(5):331–335. [PubMed] [Google Scholar]
  27. Phillips M. J., Poucell S. Modern aspects of the morphology of viral hepatitis. Hum Pathol. 1981 Dec;12(12):1060–1084. doi: 10.1016/s0046-8177(81)80328-0. [DOI] [PubMed] [Google Scholar]
  28. Rizzetto M., Shih J. W., Gerin J. L. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol. 1980 Jul;125(1):318–324. [PubMed] [Google Scholar]
  29. Rosenblate H. J., Eisenstein R., Baldwin D., Holmes A. W. Nonviral hepatitis in drug addicts. Arch Pathol. 1973 Jan;95(1):18–21. [PubMed] [Google Scholar]
  30. Seeff L. B., Zimmerman H. J., Wright E. C., Schiff E. R., Kiernan T., Leevy C. M., Tamburro C. H., Ishak K. G. Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study. Am J Med Sci. 1975 Jul-Aug;270(1):41–47. doi: 10.1097/00000441-197507000-00006. [DOI] [PubMed] [Google Scholar]
  31. Shimizu Y. K., Feinstone S. M., Purcell R. H., Alter H. J., London W. T. Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science. 1979 Jul 13;205(4402):197–200. doi: 10.1126/science.451589. [DOI] [PubMed] [Google Scholar]
  32. Stimmel B., Vernace S., Schaffner F. Hepatitis B surface antigen and antibody. A prospective study in asymptomatic drug abusers. JAMA. 1975 Dec 15;234(11):1135–1138. [PubMed] [Google Scholar]
  33. Tsiquaye K. N., Amini S., Kessler H., Bird R. G., Tovey G., Zuckerman A. J. Ultrastructural changes in the liver in experimental non-A, non-B hepatitis. Br J Exp Pathol. 1981 Feb;62(1):41–51. [PMC free article] [PubMed] [Google Scholar]
  34. Whaley W. H., Galambos J. T. Race and risk of hepatitis in narcotic addicts. Am J Dig Dis. 1973 Jun;18(6):460–466. doi: 10.1007/BF01076596. [DOI] [PubMed] [Google Scholar]
  35. Yoshizawa H., Itoh Y., Iwakiri S., Kitajima K., Tanaka A., Nojiri T., Miyakawa Y., Mayumi M. Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterology. 1981 Jul;81(1):107–113. [PubMed] [Google Scholar]
  36. Yoshizawa H., Itoh Y., Iwakiri S., Kitajima K., Tanaka A., Tachibana T., Nakamura T., Miyakawa Y., Mayumi M. Non-A, non-B (type 1) hepatitis agent capable of inducing tubular ultrastructures in the hepatocyte cytoplasm of chimpanzees: inactivation by formalin and heat. Gastroenterology. 1982 Mar;82(3):502–506. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES